Cargando…
Genetic Evolution during the development of an attenuated EIAV vaccine
BACKGROUND: The equine infectious anemia virus (EIAV) vaccine is the only attenuated lentiviral vaccine applied on a large scale that has been shown to be effective in controlling the prevalence of EIA in China. This vaccine was developed by successive passaging of a field-isolated virulent strain i...
Autores principales: | Wang, Xue-Feng, Lin, Yue-Zhi, Li, Qiang, Liu, Qiang, Zhao, Wei-Wei, Du, Cheng, Chen, Jie, Wang, Xiaojun, Zhou, Jian-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738788/ https://www.ncbi.nlm.nih.gov/pubmed/26842878 http://dx.doi.org/10.1186/s12977-016-0240-6 |
Ejemplares similares
-
Infection of equine monocyte-derived macrophages with an attenuated equine infectious anemia virus (EIAV) strain induces a strong resistance to the infection by a virulent EIAV strain
por: Ma, Jian, et al.
Publicado: (2014) -
The Soluble Form of the EIAV Receptor Encoded by an Alternative Splicing Variant Inhibits EIAV Infection of Target Cells
por: Lin, Yue-Zhi, et al.
Publicado: (2013) -
Infection with equine infectious anemia virus vaccine strain EIAV(DLV121) causes no visible histopathological lesions in target organs in association with restricted viral replication and unique cytokine response
por: Liu, Qiang, et al.
Publicado: (2016) -
Keap1 recognizes EIAV early accessory protein Rev to promote antiviral defense
por: Wang, Yan, et al.
Publicado: (2022) -
Characterization of EIAV env Quasispecies during Long-Term Passage In Vitro: Gradual Loss of Pathogenicity
por: Liu, Cong, et al.
Publicado: (2019)